Clinical trials
Amyotrophic Lateral Sclerosis trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 16 |
| Recruiting | 12 |
| Active, not recruiting | 5 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokinetics | 4 |
| Newron Sweden AB | 4 |
| Eli Lilly and Company | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Amylyx Pharmaceuticals Inc. | 2 |
| Biogen | 2 |
| Centre Hospitalier Universitaire de Liege | 2 |
| Hoffmann-La Roche | 2 |
| Humanitas Mirasole SpA | 2 |
| Knopp Biosciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 57 |
| Motor Neuron Disease | 6 |
| Parkinson Disease | 3 |
| Alzheimer Disease | 2 |
| Dementia | 2 |
| Frontotemporal Dementia | 2 |
| Lewy Body Disease | 2 |
| Brain Neoplasms | 1 |
| Epilepsy | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.